Open Your FREE Demat Account Now!

Narayana Hrudayalaya Ltd. Share Price

NSE
BSE

NSE : NH

BSE : 539551

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Low

₹1,848.50

High

₹1,887.50

Price Summary

Previous Close ₹1,868.20
Day's Range ₹1,848.50 - ₹1,887.50
Open ₹1,882.00
52 Week Range ₹1,589.00 - ₹2,092.90
Volume 76,864
Market Cap ₹0.04
Previous Close ₹1,866.75
Day's Range ₹1,850.00 - ₹1,887.90
Open ₹1,883.95
52 Week Range ₹1,564.25 - ₹2,091.55
Volume 4,309
Market Cap ₹0.04

Stocks Summary

Trade Value ( ₹ in Lacs) 1,435.97
Market Cap (₹ in Mn) 0.04
Dividend Yield(%) 0.24
Price/Earning (TTM) 44.99
TTM EPS (₹) 42.02
P/E Ratio 40.73
Book Value(₹) 7.72
PAT Margin (%) 10.26
Face Value (₹) 10.00
ROCE(%) 16.20
Trade Value ( ₹ in Lacs) 80.44
Market Cap (₹ in Mn) 0.04
Dividend Yield(%) 0.24
Price/Earning (TTM) 44.99
TTM EPS (₹) 42.02
P/E Ratio 40.73
Book Value(₹) 7.72
PAT Margin (%) 10.26
Face Value (₹) 10.00
ROCE(%) 16.20

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 16437.9 54829.77
Expenses N/A N/A
PBT 2954.82 9355.38
Operating profit 0.0 0.0
Net profit 2584.95 7906.31

Shareholding Pattern

Promoters (% Holding)

63.27%

Mutual funds (% Holding)

8.64%

Non-Institution (% Holding)

17.04%

FI/Banks/Insurance (% Holding)

1.02%

Government (% Holding)

0.00%

FII

9.01%

About Narayana Hrudayalaya Ltd.

Founded 2000
Managing Director Emmanuel Rupert
NSE Symbol NH

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,49,227.49 1,909.15 1,583.70 - 1,583.70
Divi's Laboratories Ltd. 2,93,873.72 11,090.50 5,647.50 - 5,647.50
Torrent Pharmaceuticals Ltd. 1,76,412.71 4,625.00 3,672.30 - 3,672.30
Lenskart Solutions Ltd. 1,27,350.95 738.45 0.00 - 0.00
Apollo Hospitals Enterprise Ltd. 1,26,688.66 8,734.60 6,696.50 - 6,696.50
Laurus Labs Ltd. 1,25,460.50 2,300.65 917.95 - 917.95
Zydus Lifesciences Ltd. 1,19,201.71 1,200.80 835.50 - 835.50
Dr. Reddy's Laboratories Ltd. 1,16,603.91 1,385.15 1,101.00 - 1,101.00
Cipla Ltd. 1,14,720.11 1,422.55 1,165.70 - 1,165.70
Mankind Pharma Ltd. 1,09,039.77 2,626.65 1,909.70 - 1,909.70
no-content No Records Found

Latest News

Nov
19
2026
EQUITY Posted on Nov 19th 2026

Auro Laboratories informs about SAST

Auro Laboratories has informed that it enclosed disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Siddhartha Deorah HUF.
The above information is a part of company’s filings submitted to BSE.
Read More
Nov
18
2026
EQUITY Posted on Nov 18th 2026

Godavari Drugs informs about SAST

Godavari Drugs has informed that it enclosed disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sushma Kakani.
The above information is a part of company’s filings submitted to BSE.
Read More
Nov
18
2026
EQUITY Posted on Nov 18th 2026

Ajanta Pharma informs about disclosure

Ajanta Pharma has informed that the exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 18, 2026 for Aayush Agrawal, trustee Aayush Agrawal Trust.

The above information is a part of company’s filings submitted to BSE.

Read More
Nov
18
2026
EQUITY Posted on Nov 18th 2026

FDC informs about open offer updates

FDC has informed that Sundae Capital Advisors (Manager to the Offer) has submitted a copy of Offer Opening Advertisement cum Corrigendum to the Public Announcement for the Buyback of Equity Shares on a proportionate basis through Tender Offer under the Securities and Exchange Board of India (Buyback of Securities) Regulations, 2018, (SEBI Buyback Regulations) as amended for the attention of Equity Shareholders / Beneficial Owners of the Equity Shares of FDC (the Company). 
The above information is a part of company’s filings submitted to BSE.
Read More
Nov
18
2026
EQUITY Posted on Nov 18th 2026

Aurobindo Pharma submits notice of postal ballot

Aurobindo Pharma has informed that it enclosed a copy of the Postal Ballot Notice dated November 4, 2026 together with the Explanatory Statement thereto, seeking approval of the Members for: Reappointment of Mangalam Ramasubramanian Kumar (DIN: 03628755), as an Independent Director of the Company not liable to retire by rotation, for a second term of 5 (Five) consecutive years commencing from April 1, 2027 to March 31, 2032; Revision of remuneration of K. Nithyananda Reddy (DIN: 01284195), Vice Chairman & Managing Director of the Company; Revision of remuneration of Dr. M. Madan Mohan Reddy (DIN: 01284266), Whole-time Director of the Company; Revision in the commission payable to the independent directors of the Company.
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Narayana Hrudayalaya Ltd. ?

The current share price of Narayana Hrudayalaya Ltd. is ₹1,868.20 as of 2026-11-19.

The market capitalisation of Narayana Hrudayalaya Ltd. is ₹38,635.43 as of 2026-11-18.

The 1-year return of Narayana Hrudayalaya Ltd. is -83.50% as of 2026-11-19.

The P/E ratio of Narayana Hrudayalaya Ltd. is 40.73 as of 2026-11-19.

The 52-week high and low of Narayana Hrudayalaya Ltd. are ₹2,092.90 and ₹1,589.00, respectively, as of 2026-11-19.

The dividend yield of Narayana Hrudayalaya Ltd. is 0.238% as of2026-11-18.

You can buy Narayana Hrudayalaya Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Narayana Hrudayalaya Ltd. is Emmanuel Rupert.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

People Also Ask

In what ways does Narayana Hrudayalaya Ltd. establish partnerships within the hospital and pharmaceutical ecosystem?

Narayana Hrudayalaya Ltd. establishes partnerships by collaborating with regional governments to operate specialised public-private healthcare facilities. The hospital chain also works closely with medical technology firms to implement advanced, cost-effective surgical equipment across its network.

Narayana Hrudayalaya Ltd. provides extensive multi-specialty healthcare facilities, operating a network of over 40 hospitals and primary care clinics. The enterprise is globally ren

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore